Recurrent Pancreatic Carcinoma Active Not Recruiting Phase 2 Trials for Pertuzumab (DB06366)

Also known as: Pancreatic carcinoma recurrent / Pancreas carcinoma recurrent / Pancreatic cancer recurrent